Reminyl CR 8 mg


Prolonged Release Capsules
scheduling status
S4
registration number
38/5.3/0311
What Reminyl CR 8 mg contains
Galantamine hydrobromide.
other ingredients
Diethyl phthalate, ethyl cellulose, gelatin, hypromellose, maize starch, macrogol, sucrose and titanium dioxide (E171).
Therapeutic classification
A. 5.3 - Cholinomimetics.
© 2026 SAHPRA. ALL RIGHTS RESERVED